Skip to content
  1. Home
  2. Stacks
  3. BPC-157 + TB-500 + GHK-Cu

Peptide stack

BPC-157 + TB-500 + GHK-Cu

The base recovery stack plus a collagen-remodeling peptide.

Also known as: GLOW stack

Components studied separately, not the combination

Reviewed 2026-09-12
Not a recommendation. This page explains why a combination is discussed together in research or community circles — it is not an endorsement of stacking these compounds. See each component's own page for full detail, dosing and safety notes.

COMPONENTS in this stack

Why these are combined

BPC-157 for systemic healing, TB-500 for angiogenesis and fibroblast migration, GHK-Cu for collagen synthesis and tissue remodeling. Each has its own wound-healing evidence, but nobody has tested the three together, so any added benefit from combining them is assumed, not measured.

Mechanism & pharmacokinetics

Adds a third, mechanistically separate pathway to the BPC-157/TB-500 base: GHK-Cu acts through copper-dependent modulation of matrix metalloproteinases and direct effects on collagen and fibroblast gene expression, distinct from BPC-157's growth-factor-receptor route and TB-500's actin-binding route. Like the other two, GHK-Cu clears from plasma quickly, but its reported effects (collagen remodeling, wound-site gene expression changes) are described as outlasting its circulating presence, similar in shape to TB-500's profile. Because none of the three peptides are reported to compete for the same receptor or enzyme system, the theoretical case against pharmacodynamic interference is reasonable — but again, nobody has run the three-way combination as a study; this is inference from three separate evidence bases, not a tested one. The 'GLOW' name reflects the cosmetic/skin angle GHK-Cu adds on top of the base recovery stack, not a literal acronym of the ingredients.

Citations

Typical community protocol

BPC-157 250-500 mcg daily, TB-500 2-4 mg weekly, GHK-Cu 200-300 mcg 3-4x weekly. Commonly run 8-12 weeks, subcutaneous injection.

Safety notes

Safety: Stacking three growth-factor and angiogenesis drivers could, in theory, push toward excess scar tissue with prolonged use. No data on the combined regimen exists either way.
Community notes (anecdotal — not clinical evidence)

Called the 'full healing stack' in recovery forums. Popular for post-injury and post-surgical use despite zero trial data on the three-way combination.